Zygmunt Peter M, Högestätt Edward D
Clinical and Experimental Pharmacology, Clinical Chemistry, Department of Laboratory Medicine, Lund University, Skåne University Hospital, SE-221 85, Lund, Sweden,
Handb Exp Pharmacol. 2014;222:583-630. doi: 10.1007/978-3-642-54215-2_23.
The transient receptor potential ankyrin subtype 1 protein (TRPA1) is a nonselective cation channel permeable to Ca(2+), Na(+), and K(+). TRPA1 is a promiscuous chemical nocisensor that is also involved in noxious cold and mechanical sensation. It is present in a subpopulation of Aδ- and C-fiber nociceptive sensory neurons as well as in other sensory cells including epithelial cells. In primary sensory neurons, Ca(2+) and Na(+) flowing through TRPA1 into the cell cause membrane depolarization, action potential discharge, and neurotransmitter release both at peripheral and central neural projections. In addition to being activated by cysteine and lysine reactive electrophiles and oxidants, TRPA1 is indirectly activated by pro-inflammatory agents via the phospholipase C signaling pathway, in which cytosolic Ca(2+) is an important regulator of channel gating. The finding that non-electrophilic compounds, including menthol and cannabinoids, activate TRPA1 may provide templates for the design of non-tissue damaging activators to fine-tune the activity of TRPA1 and raises the possibility that endogenous ligands sharing binding sites with such non-electrophiles exist and regulate TRPA1 channel activity. TRPA1 is promising as a drug target for novel treatments of pain, itch, and sensory hyperreactivity in visceral organs including the airways, bladder, and gastrointestinal tract.
瞬时受体电位锚蛋白1亚型蛋白(TRPA1)是一种对Ca(2+)、Na(+)和K(+)通透的非选择性阳离子通道。TRPA1是一种混杂的化学伤害感受器,也参与有害冷觉和机械感觉。它存在于Aδ和C纤维伤害性感觉神经元的一个亚群以及包括上皮细胞在内的其他感觉细胞中。在初级感觉神经元中,Ca(2+)和Na(+)通过TRPA1流入细胞会导致膜去极化、动作电位发放以及在外周和中枢神经投射处释放神经递质。除了被半胱氨酸和赖氨酸反应性亲电试剂及氧化剂激活外,TRPA1还通过磷脂酶C信号通路被促炎剂间接激活,其中胞质Ca(2+)是通道门控的重要调节因子。包括薄荷醇和大麻素在内的非亲电化合物能激活TRPA1这一发现,可能为设计无组织损伤的激活剂以微调TRPA1的活性提供模板,并增加了存在与这类非亲电试剂共享结合位点的内源性配体并调节TRPA1通道活性的可能性。TRPA1有望成为治疗包括气道、膀胱和胃肠道在内的内脏器官疼痛、瘙痒和感觉过敏的新型药物靶点。